Phase III clinical trial for India’s 1st dengue vaccine kicks off at KIMS
Bhubaneswar: The third phase of the clinical trial for India’s first indigenous dengue vaccine, ‘DengiAll,’ commenced at the Kalinga Institute ...
Read moreBhubaneswar: The third phase of the clinical trial for India’s first indigenous dengue vaccine, ‘DengiAll,’ commenced at the Kalinga Institute ...
Read moreCuttack: A clinical trial at SCB Dental College and Hospital in Cuttack, Odisha, has revealed that combining Nicotine Replacement Therapy ...
Read moreNew Delhi: The Central Drugs Standard Control Organisation (CDSCO), India's National Regulatory Authority, has approved Gennova Biopharmaceuticals Limited's work on ...
Read moreNew Delhi: The Delhi High Court Wednesday sought the Centre's response on a plea seeking to set aside the permission ...
Read moreNew Delhi: The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of ...
Read moreNew Delhi: A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that COVID-19 patients ...
Read moreNew Delhi: The Indian Council of Medical Research (ICMR) said on Tuesday three vaccine candidates against the coronavirus disease (Covid-19) ...
Read moreWashington: Researchers across the US have stepped up efforts towards the development of an effective Covid-19 vaccine, as another vaccine ...
Read moreNew Delhi: Six Indian companies are working on a vaccine for COVID-19. They have joined the global race against time ...
Read moreAn oral, inactivated vaccine candidate against enterotoxigenic E. coli diarrohea has been found safe for infants and children in a ...
Read more